Quantcast
Environmental Health Perspectives Reader Survey
Author Keyword Title Full
About EHP Publications Past Issues News By Topic Authors Subscribe Press International Inside EHP Email Alerts spacer
Environmental Health Perspectives (EHP) is a monthly journal of peer-reviewed research and news on the impact of the environment on human health. EHP is published by the National Institute of Environmental Health Sciences and its content is free online. Print issues are available by paid subscription.DISCLAIMER
spacer
NIEHS
NIH
DHHS
spacer
Current Issue





Blueprint for Children?s Health and the Built Environment
Presented by the Children's Environmental Health Institute

Comparative Toxicogenomics Database (CTD)

Environmental Health News

spacer
Environmental Health Perspectives Volume 116, Number 5, May 2008 Open Access
spacer
The Polybrominated Diphenyl Ether Mixture DE-71 Is Mildly Estrogenic

Minerva Mercado-Feliciano1 and Robert M. Bigsby2

1Department of Pharmacology and Toxicology, and 2Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, Indiana, USA

Abstract
Background: Polybrominated diphenyl ethers (PBDEs) are widely found in the environment, and they may act as endocrine disruptors.

Objective: Our goal in this study was to test the PBDE mixture DE-71 for estrogenic activity.

Methods: We used proliferation of cultured breast cancer cells (MCF-7) and trophic effects in the reproductive tracts of ovariectomized mice as estrogen bioassays. DE-71 was administered to mice by subcutaneous injection (sc) or oral gavage (po) , alone or in combination with estradiol, for 3 or 34 days. Liver weights and cytochrome P450 enzyme activities were also measured.

Results: DE-71 increased MCF-7 cell proliferation, and this was prevented by antiestrogen. DE-71 cotreatment reduced the effect of estradiol in MCF-7 cells. In the mouse 3-day assay, DE-71 administered alone had no effect on uterine weight, uterine epithelial height (UEH) , or vaginal epithelial thickness (VET) ; however, when DE-71 was administered as a cotreatment, it potentiated estradiol's effect on uterine weight. DE-71 administered sc to BALB/c mice for 34 days slightly increased UEH and VET, and attenuated the estradiol-induced increase in UEH ; these effects were not seen in BALB/c mice treated po or in C57BL/6 mice treated sc. DE-71 increased liver weight in BALB/c, C57BL/6, and estrogen receptor-α knockout mice. We also found an increase in liver cytochrome P450 1A (CYP1A) and CYP2B activities when DE-71 was administered po, but only CYP2B increased after sc treatment.

Conclusion: DE-71 behaves as a weak estrogen. In mice, the treatment route and duration determined if DE-71 was estrogenic. BALB/c mice are more susceptible to DE-71 effects in estrogen target tissues than C57BL/6 mice. DE-71 increased liver weight independently of estrogen receptor-α.

Key words: , , , , , , , , , . Environ Health Perspect 116:605–611 (2008) . doi:10.1289/ehp.10643 available via http://dx.doi.org/ [Online 29 January 2008]


Address correspondence to R.M. Bigsby, Department of Obstetrics and Gynecology, Indiana University School of Medicine, 975 W. Walnut St. (IB360) , Indianapolis, IN 46202-5121 USA. Telephone: (317) 274-8970. Fax: (317) 278-2884. E-mail: rbigsby@iupui.edu

We thank G. Eckert for assistance with the statistical analyses.

This work was supported by grants ES013341 and ES014367 from the National Institute of Environmental Health Sciences.

The authors declare they have no competing financial interests.

Received 7 July 2007 ; accepted 25 January 2008.


The full version of this article is available for free in HTML or PDF formats.
spacer
 
Open Access Resources | Call for Papers | Career Opportunities | Buy EHP Publications | Advertising Information | Subscribe to the EHP News Feeds News Feeds | Inspector General USA.gov